[MP-202544] Mezigdomide (multiple myeloma)
Last updated 22.07.2026
Project no.:
MP-202544
Report type:
Joint Clinical Assessment, JCA
Status:
Commission work started
Department/Division:
Drug Assessment
Topic:
Cancer
Indication:
Treatment of multiple myeloma
Note:
This Joint Clinical Assessment (JCA) is being conducted in cooperation with the Agency for Health Technology Assessment and Tariff System (AOTMiT) Poland.
Further background information can be found here: European health technology assessment
| Stage | Date |
|---|---|
| Start | 2nd quarter, 2026 |
| voraussichtlicher Abschluss | 3rd quarter, 2027 |